Valneva

Gold Sponsor

Valneva is a fully integrated vaccine company that specializes in the development, manufacture and commercialization of innovative vaccines with a mission to protect people from infectious diseases through preventative medicine. 

Valneva’s portfolio includes two commercial vaccines for travelers: IXIARO®/JESPECT® for the prevention of Japanese Encephalitis, and DUKORAL® indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by LT-ETEC.

The Company has proprietary vaccines in development including candidates against Pseudomonas aeruginosa, Clostridium difficile and Lyme borreliosis.

Valneva is listed on Euronext-Paris and the Vienna stock exchange and has operations in France, Austria, Scotland, Canada and Sweden.

website